scispace - formally typeset
G

Guido Kroemer

Researcher at Institut Gustave Roussy

Publications -  1546
Citations -  294816

Guido Kroemer is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Programmed cell death & Apoptosis. The author has an hindex of 236, co-authored 1404 publications receiving 246571 citations. Previous affiliations of Guido Kroemer include Karolinska Institutet & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.

TL;DR: In this article, the authors show that hTERT depletion has no adverse effects on the viability or proliferation of cervical and colon carcinoma cell lines, as evaluated within 72 h after transfection with hTERTs-specific small interfering RNAs (siRNAs).
Journal ArticleDOI

Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event.

TL;DR: In Rat-1 cells, a Bcl-2 mutant targeted exclusively to the endoplasmic reticulum (Bcl-cb5) was effective at inhibiting apoptosis induced by serum starvation/myc, or ceramide but not apoptosisinduced by etoposide.
Journal ArticleDOI

The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?

TL;DR: This review summarizes recent publications addressing the impact of the gut microbiome on ICI efficacy, discusses currently available data on the effect of ATB administered in different time-frames respect to ICI initiation, and discusses the therapeutic implications of these findings.
Journal ArticleDOI

Pyroptosis - a cell death modality of its kind?

TL;DR: The term “pyroptosis” was originally introduced to describe a particular form of cell death in macrophages, which is induced by bacterial infection, is accompanied by caspase‐1 activation and hence leads to the release of pyrogenic interleukins.
Journal ArticleDOI

Caspase-dependent and caspase-independent cell death pathways in yeast.

TL;DR: Yeast constitutes an excellent model organism to delineate phylogenetically conserved pathways leading to apoptotic or necrotic cell death and can be used to identify pharmacological and genetic modulators of cell death pathways that are relevant for human disease.